亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism

医学 肺栓塞 回顾性队列研究 内科学 置信区间 队列 单变量 逻辑回归 队列研究 心脏病学 多元统计 外科 统计 数学
作者
David Jiménez
出处
期刊:Archives of internal medicine [American Medical Association]
卷期号:170 (15): 1383-1383 被引量:1135
标识
DOI:10.1001/archinternmed.2010.199
摘要

The Pulmonary Embolism Severity Index (PESI) estimates the risk of 30-day mortality in patients with acute pulmonary embolism (PE). We constructed a simplified version of the PESI.The study retrospectively developed a simplified PESI clinical prediction rule for estimating the risk of 30-day mortality in a derivation cohort of Spanish outpatients. Simplified and original PESI performances were compared in the derivation cohort. The simplified PESI underwent retrospective external validation in an independent multinational cohort (Registro Informatizado de la Enfermedad Tromboembólica [RIETE] cohort) of outpatients.In the derivation data set, univariate logistic regression of the original 11 PESI variables led to the removal of variables that did not reach statistical significance and subsequently produced the simplified PESI that contained the variables of age, cancer, chronic cardiopulmonary disease, heart rate, systolic blood pressure, and oxyhemoglobin saturation levels. The prognostic accuracy of the original and simplified PESI scores did not differ (area under the curve, 0.75 [95% confidence interval (CI), 0.69-0.80]). The 305 of 995 patients (30.7%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.0% (95% CI, 0.0%-2.1%) compared with 10.9% (8.5%-13.2%) in the high-risk group. In the RIETE validation cohort, 2569 of 7106 patients (36.2%) who were classified as low risk by the simplified PESI had a 30-day mortality of 1.1% (95% CI, 0.7%-1.5%) compared with 8.9% (8.1%-9.8%) in the high-risk group.The simplified PESI has similar prognostic accuracy and clinical utility and greater ease of use compared with the original PESI.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
充电宝应助欢呼沅采纳,获得10
4秒前
赘婿应助曲幻梅采纳,获得10
16秒前
Hello应助Founder采纳,获得30
22秒前
29秒前
30秒前
34秒前
ph完成签到 ,获得积分10
38秒前
苏震坤发布了新的文献求助10
43秒前
46秒前
乐正亦寒完成签到 ,获得积分10
56秒前
1分钟前
fabius0351完成签到 ,获得积分10
1分钟前
Lululu发布了新的文献求助10
1分钟前
渡边曜应助健康的雁风采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
曲幻梅发布了新的文献求助10
1分钟前
神火发布了新的文献求助10
1分钟前
2分钟前
HXY发布了新的文献求助10
2分钟前
英俊的铭应助HXY采纳,获得10
2分钟前
2分钟前
Founder发布了新的文献求助30
2分钟前
打打应助科研通管家采纳,获得10
2分钟前
3分钟前
3分钟前
周炎发布了新的文献求助10
3分钟前
丘比特应助乌云采纳,获得10
3分钟前
欢呼沅发布了新的文献求助10
3分钟前
Orange应助欢呼沅采纳,获得20
3分钟前
打打应助周炎采纳,获得10
3分钟前
Ava应助liu采纳,获得10
3分钟前
3分钟前
3分钟前
苏震坤发布了新的文献求助10
3分钟前
乌云发布了新的文献求助10
3分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Weaponeering, Fourth Edition – Two Volume SET 1000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Handbook of pharmaceutical excipients, Ninth edition 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5996785
求助须知:如何正确求助?哪些是违规求助? 7470296
关于积分的说明 16080986
捐赠科研通 5139809
什么是DOI,文献DOI怎么找? 2756030
邀请新用户注册赠送积分活动 1730345
关于科研通互助平台的介绍 1629664